In case you missed them, here are the 10 most widely read articles and widely viewed videos on for the past two days (as of Oct. 11). Adam Feuerstein suggests that Alzheimer's drug stocks may be worth the wait, and James Altucher finds 10 stocks with big insider buying and buybacks.

1. Top 10 Stocks With Big Insider Buying, Buybacks by James Altucher, published Oct. 11 at 5:42 a.m. EDT.

Large repurchases put ConAgra and NutriSystem on the list of stocks to watch.

2. The Top Dividend Stocks of the Week by James Altucher, published Oct. 10 at 5:47 a.m. EDT.

These are the latest stocks to reward investors with a raised dividend the week ended Oct. 7.

3. This Week's Rocket Stocks Portfolio Update by James Altucher, published Oct. 10 at 9:43 a.m. EDT.

One additional pick.

4. Another New High for VMware by Ivy Lessner, published Oct. 10 at 4:34 p.m. EDT.

The stock has put up a two-day gain of 12.6%.

5. Cramer: VMWare Could Throw Amazon From the Horseman's Saddle by Jim Cramer and Farnoosh Torabi, published Oct. 10 at 12:55 p.m. EDT.

Jim Cramer discusses VMWare as a potential tech horseman, and why he thinks the stock has tremendous growth ahead.

6. Thursday's Analysts' Upgrades and Downgrades by TSC Staff, published Oct. 11 at 10:23 a.m. EDT.

Who made what calls.

7. You Ask, Cramer Answers by Stockpickr Staff, published Oct. 11 at 10:19 a.m. EDT.

Jim Cramer answers questions on CVS, beverage stocks and more.

8. Alzheimer's Drug Stocks May Be Worth Wait by Adam Feuerstein, published Oct. 10 at 12:38 p.m. EDT.

The payoff may come later, but these focused companies should still get a look.

9. Tomorrow's Headliners: GE, Apple by TSC Staff, published Oct. 11 at 8:36 p.m. EDT.

Investors will also be treated to another round of economic data, including the PPI.

10. Boeing Delays Dreamliner by Ted Reed, published Oct. 10 at 1:01 p.m. EDT.

Initial deliveries are being pushed back by six months.
David Morrow is editor-in-chief of In keeping with TSC's editorial policy, he doesn't own or short individual stocks, though he owns stock in He also doesn't invest in hedge funds or other private investment partnerships. He appreciates your feedback; click here to send him an email.